256 related articles for article (PubMed ID: 26600225)
1. Current Treatment Options in Patients with Hepatitis C Virus Genotype 6.
Nguyen NH; Nguyen MH
Gastroenterol Clin North Am; 2015 Dec; 44(4):871-81. PubMed ID: 26600225
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus: Current and Evolving Treatments for Genotype 4.
Asselah T; Bourlière M
Gastroenterol Clin North Am; 2015 Dec; 44(4):859-70. PubMed ID: 26600224
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection.
Everson GT; Sims KD; Rodriguez-Torres M; Hézode C; Lawitz E; Bourlière M; Loustaud-Ratti V; Rustgi V; Schwartz H; Tatum H; Marcellin P; Pol S; Thuluvath PJ; Eley T; Wang X; Huang SP; McPhee F; Wind-Rotolo M; Chung E; Pasquinelli C; Grasela DM; Gardiner DF
Gastroenterology; 2014 Feb; 146(2):420-9. PubMed ID: 24184132
[TBL] [Abstract][Full Text] [Related]
5. [Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].
Zuckerman E; Safadi R; Oren R; Shibolet O; Baruch Y; Bruck R; Lurei Y; Kaspa RT; Abu-Mouch S; Shouval D; Ben-Ari Z;
Harefuah; 2012 Dec; 151(12):709-14, 719. PubMed ID: 23330266
[TBL] [Abstract][Full Text] [Related]
6. [Antiviral treatment of chronic hepatitis C].
Berger A
Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.
Ampuero J; Romero-Gómez M
Gastroenterol Clin North Am; 2015 Dec; 44(4):845-57. PubMed ID: 26600223
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies for hepatitis C virus.
Birerdinc A; Younossi ZM
Expert Opin Emerg Drugs; 2010 Dec; 15(4):535-44. PubMed ID: 20629602
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus: standard-of-care treatment.
Pawlotsky JM
Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001
[TBL] [Abstract][Full Text] [Related]
10. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
Welsch C; Jesudian A; Zeuzem S; Jacobson I
Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918
[TBL] [Abstract][Full Text] [Related]
11. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
12. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hepatitis C virus--2012: a real breakthrough].
Zuckerman E
Harefuah; 2012 Dec; 151(12):699-704, 719. PubMed ID: 23330264
[TBL] [Abstract][Full Text] [Related]
14. Current and Evolving Treatments of Genotype 1 Hepatitis C Virus.
Alqahtani S; Sulkowski M
Gastroenterol Clin North Am; 2015 Dec; 44(4):825-43. PubMed ID: 26600222
[TBL] [Abstract][Full Text] [Related]
15. HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy.
Chayama K; Hayes CN
Viruses; 2015 Oct; 7(10):5328-42. PubMed ID: 26473914
[TBL] [Abstract][Full Text] [Related]
16. Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time.
Cuypers L; Ceccherini-Silberstein F; Van Laethem K; Li G; Vandamme AM; Rockstroh JK
Rev Med Virol; 2016 Nov; 26(6):408-434. PubMed ID: 27401933
[TBL] [Abstract][Full Text] [Related]
17. Pan-genotypic treatment regimens for hepatitis C virus: Advantages and disadvantages in high- and low-income regions.
Hézode C
J Viral Hepat; 2017 Feb; 24(2):92-101. PubMed ID: 27862695
[TBL] [Abstract][Full Text] [Related]
18. Urgency to treat patients with chronic hepatitis C in Asia.
Kao JH; Ahn SH; Chien RN; Cho M; Chuang WL; Jeong SH; Liu CH; Paik SW
J Gastroenterol Hepatol; 2017 May; 32(5):966-974. PubMed ID: 28005275
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C treatment highlights from the 2011 American Association for the Study of Liver Disease meeting.
Cooper C
Clin Infect Dis; 2012 Aug; 55(3):418-25. PubMed ID: 22491342
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C: An Eastern Perspective.
Dan YY; Lim SG
Gastroenterol Clin North Am; 2015 Dec; 44(4):793-805. PubMed ID: 26600220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
